“…In our efforts to further harness the 1,2-dihydropyridine intermediates generated through Rh-catalyzed C–H activation, we became interested in the potential of generating isoquinuclidines utilizing a Diels–Alder reaction (Scheme B). Isoquinuclidines have been used as intermediates in the preparation of tetrahydroisoquinoline alkaloids, piperidines, Iboga alkaloids, and the related Cantharanthus alkaloids, which have been developed as cancer therapeutics. Isoquinuclidines are most often prepared by a Diels–Alder reaction of 1,2-dihydropyridines generated by N -acylation followed by nucleophilic addition to pyridines. − However, the incorporation of an acyl protecting group attenuates the nucleophilicity of the dihydropyridine substrates .…”